Further examination of regulation of HIF1α under normoxia and hypoxia may provide additional insight into its in GBM pathophysiology [37] and interacting factors may provide alternative therapeutic targets for the treatment of GBM. This evidence concerns the gene HIF1A and glioblastoma.